PO-0616: HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC
PO-0616: HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC
Linge, A.; Löck, S.; Krenn, C.; Appold, S.; Lohaus, F.; Schneider, M.; Nowak, A.; Gudziol, V.; Baretton, G. B.; Buchholz, F.; Baumann, M.; Krause, M.
Abstract
PO-0616: HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC
-
Abstract in referierter Zeitschrift
Radiation Oncology 123(2017), s322
DOI: 10.1016/S0167-8140(17)31053-8
Permalink: https://www.hzdr.de/publications/Publ-26997
